| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
490,255 |
$1,485,472 |
$3.03 |
23 Dec 2025 |
By Proehl Family Trust |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
122,563 |
$371,365 |
$3.03 |
23 Dec 2025 |
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 |
| TENAX THERAPEUTICS, INC. |
Director |
Pre-Funded Warrant |
31,654 |
$284,886 |
$9.00 |
09 Jan 2026 |
Direct |
| TENAX THERAPEUTICS, INC. |
Director |
Stock Option (right to buy) |
30,000 |
$270,000 |
$9.00 |
09 Jan 2026 |
Direct |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
79,795 |
$241,778 |
$3.03 |
23 Dec 2025 |
By Proehl Investment Ventures LLC |
| TENAX THERAPEUTICS, INC. |
Director |
Warrant |
16,660 |
$149,940 |
$9.00 |
09 Jan 2026 |
Direct |
| TENAX THERAPEUTICS, INC. |
Director |
Common Stock |
1,667 |
$15,003 |
$9.00 |
09 Jan 2026 |
Direct |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
24 |
$72 |
$3.03 |
23 Dec 2025 |
Direct |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
7 |
$21 |
$3.03 |
23 Dec 2025 |
By Allison Taylor Proehl 2020 Irrevocable Trust |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
3 |
$9 |
$3.03 |
23 Dec 2025 |
By Meghan Proehl Wilder 2020 Irrevocable Trust |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Warrant (Right to Buy) |
787,402 |
|
|
21 Jan 2025 |
By Proehl Investment Ventures LLC |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Series C Warrant (Right to Buy) |
490,496 |
|
|
23 Dec 2025 |
By Proehl Family Trust |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Series D Warrant (Right to Buy) |
490,496 |
|
|
23 Dec 2025 |
By Proehl Family Trust |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Series C Warrant (Right to Buy) |
122,549 |
|
|
23 Dec 2025 |
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Series D Warrant (Right to Buy) |
122,549 |
|
|
23 Dec 2025 |
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Warrant (Right to Buy) |
78,740 |
|
|
23 Dec 2025 |
Direct |
| Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Stock Option (right to buy) |
37,500 |
|
|
02 Jan 2026 |
Direct |